NDASA does not ship physical goods from purchases.
Search this site
Stay in touch
Give to NDASA
Invest in safe and drug-free communities and workplaces and support NDASA.
Latest News & Updates
- Apr 26, 2024Be The Voice: NDASA members, we want to feature you in the next issue of our industry e-magazine
- Apr 24, 2024Turning strangers into customers: Leverage incoming calls to boost your sales
- Apr 12, 2024The value of townhalls
- Apr 12, 2024May is Mental Health Awareness Month
- Apr 12, 2024Drugs you need to be testing for this quarter – Recommended scope for novel psychoactive substance (NPS) testing in the U.S.
Topics We Track
- Advocacy (5)
- Business Development (5)
- Committee Reports (1)
- DOT (11)
- Drug & Alcohol Testing (42)
- Drug Legislation (10)
- Feature (90)
- FMCSA (7)
- For Drug Testing Industry Professionals (15)
- For Employers and Workplace Safety & Wellness Professionals (15)
- Industry News (26)
- Marijuana & CBD (16)
- Member Benefits (3)
- Membership (6)
- NDASA Conference (13)
- NDASA Guidance (4)
- NDASA News (3)
- Newsletter Only (5)
- Opioids (2)
- Resources (24)
- Substance Use (3)
- Substance Use/Addiction (8)
- Training (3)
- Uncategorized (12)
- Workplace Safety (10)
- Be The Voice: NDASA members, we want to feature you in the next issue of our industry e-magazine
- Turning strangers into customers: Leverage incoming calls to boost your sales
- The value of townhalls
- May is Mental Health Awareness Month
- Drugs you need to be testing for this quarter – Recommended scope for novel psychoactive substance (NPS) testing in the U.S.